Registration is now open for the next edition of WorldLeish, the  premier congress for leishmaniasis expected to attract around 1500 participants including scientific experts and health decision-makers, WHO representatives, and governments representatives from endemic countries, and all major organizations involved in the fight against leishmaniasis.

Submit your abstract by the 30 November deadline and save the date to join us in Toledo, Spain, on 16-20th May 2017.

Co-organized by the WHO Collaborating Centre for Leishmaniasis of the Instituto de Salud Carlos III (Madrid, Spain) and the Drugs for Neglected Diseases initiative (DNDi, Geneva, Switzerland), the Congress scientific programme will cover all scientific and policy aspects of leishmaniasis today:

– from basic research to disease control and elimination – as targeted by the WHO Roadmap for Neglected Tropical Diseases and the 2012 ‘London Declaration’;

– with a focus on patients’ needs but also sessions on canine leishmaniasis and vector research;

– with dedicated symposia on drug discovery, trial standardisation, and advocacy to discuss the way forward with experts and key actors;


WorldLeish is also partnering with PLOS journals on a Special Collection on leishmaniasis that will compile publications on the key topics discussed at the Congress. Submission for articles is now open, with publication of the first articles in the series (which will be updated until the Congress) coming soon. More information:


Dr Jorge Alvar, chair, and Dr Javier Moreno, co-chair

on behalf of the Organizing Committee of WL6